Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study (original) (raw)

Dosing guidelines for fluconazole in patients with renal failure

Vincent Launay-vacher

Nephrology Dialysis Transplantation, 2003

View PDFchevron_right

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

Tobias Bingold

Infection and Drug Resistance, 2013

View PDFchevron_right

Empirical Fluconazole versus Placebo for Intensive Care Unit Patients

Susan McCormick Hadley

Annals of Internal Medicine, 2008

View PDFchevron_right

HPLC Assay of Fluconazole and Its Application to Patients with Early Septic Shock

Nouf Aloudah

Journal of Liquid Chromatography & Related Technologies, 2005

View PDFchevron_right

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid

Martin Mayers

Antimicrobial Agents and Chemotherapy, 1994

View PDFchevron_right

Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing Keywords average bioequivalence -fluconazole -multiple dosing -bioequivalence metrics -interindividual variability Received

Kristina Bozhinova

View PDFchevron_right

Pharmacokinetics of fluconazole in people with HIV infection: a population analysis

Andrew McLachlan

British Journal of Clinical Pharmacology, 2003

View PDFchevron_right

Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration

Michael Roberts

International journal of antimicrobial agents, 2015

View PDFchevron_right

Bioequivalence of Two Oral Fluconazole Formulations in Healthy Subjects: a Single Dose, Open-Label, Randomized, Two-Period Crossover Study

Teresita Vargas Castro

Journal of Bioequivalence & Bioavailability, 2010

View PDFchevron_right

Co-administration of Fluoxetine Alters the Steady State Pharmacokinetics of Fluconazole after Multiple Oral Administration in Dogs

Iman Zaghloul

Scholarly Research Exchange, 2009

View PDFchevron_right

Fluconazole Loading Dose Pharmacokinetics and Safety in Infants

Lauren Piper

Pediatric Infectious Disease Journal, 2011

View PDFchevron_right

Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers

Chinedum P E A C E Babalola

Journal of Clinical Pharmacy and Therapeutics, 2009

View PDFchevron_right

A Review on Fluconazole

Navreet Kaur

Journal for Research in Applied Sciences and Biotechnology, 2023

View PDFchevron_right

Drug–drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment

Erik Wilms

Journal of Antimicrobial Chemotherapy, 2023

View PDFchevron_right

Standardized susceptibility testing of fluconazole: an international collaborative study

B. Dupont

Antimicrobial Agents and Chemotherapy, 1992

View PDFchevron_right

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg

M. Hoffmann

Nephrology Dialysis Transplantation, 2005

View PDFchevron_right

Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration

Natasha Ornelas Lopez

Pharmacotherapy, 2014

View PDFchevron_right

Anidulafungin compared with fluconazole therapy in critically ill patients

Haran Schlamm

Critical Care, 2010

View PDFchevron_right

Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure

Porpon Rotjanapan

Australasian Medical Journal

View PDFchevron_right

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

E. Tuomanen

Antimicrobial Agents and Chemotherapy, 1988

View PDFchevron_right

Gender Differences in the Oral Pharmacokinetics of Fluconazole

MIRIAM DEL CARMEN CARRASCO-PORTUGAL

Clinical Drug Investigation, 2007

View PDFchevron_right

Risk factors for subtherapeutic levels of posaconazole tablet

Lydia Benitez

Journal of Antimicrobial Chemotherapy

View PDFchevron_right

Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure: A case report

Porpon Rotjanapan

Australasian Medical Journal, 2017

View PDFchevron_right

In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis

Jeffrey Lipman

Antimicrobial Agents and Chemotherapy, 2015

View PDFchevron_right

Population Pharmacokinetics of Fluconazole in Young Infants

Ramasubbareddy Dhanireddy

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study

Tyree Kiser

Annals of Clinical Microbiology and Antimicrobials

View PDFchevron_right

Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men

Muhammad Hammami

Biopharmaceutics & Drug Disposition, 2005

View PDFchevron_right

Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers

Lei Ma

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit

Stefan Höfer

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients

J. Kosterink

Antimicrobial Agents and Chemotherapy, 2021

View PDFchevron_right

Bicequivalence Evaluation of Two Formulations of Fluconazole 150 mg Capsule in Healthy Arab Men

Muhammad Hammami

View PDFchevron_right

Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*

Kevin Chung

Critical Care Medicine, 2005

View PDFchevron_right

Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects

Maria Caceres

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients

Dr. Abdulaziz S Al Obaid

Antimicrobial Agents and Chemotherapy, 2016

View PDFchevron_right

The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans

Kaveh Zamani

Clinical Pharmacology & Therapeutics, 1993

View PDFchevron_right